First-in-human trial of novel oral PARP inhibitor BMN 673 in patients with solid tumors
暂无分享,去创建一个
D. Matei | N. Curtin | J. Bono | L. Byers | Z. Wainberg | S. Kaye | A. Dorr | J. Sachdev | Joshua Henshaw | R. Chugh | B. Basu | R. Ramanathan | G. Jameson | Michael A. Gonzalez | M. Chadha | L. Mina | M. Ong | Evelyn Wang